Skip to main content

Resorcinol / sulfur topical Pregnancy and Breastfeeding Warnings

Brand names: Acnomel, Acnotex, Bensulfoid, Rezamid, Sulforcin

Resorcinol / sulfur topical Pregnancy Warnings

The manufacturer makes no recommendation regarding use during pregnancy.

AU TGA pregnancy category: Not formally assigned to a pregnancy category.
US FDA pregnancy category: Not formally assigned to a pregnancy category.

Animal studies have not been reported. There are no controlled data in human pregnancy.

See references

Resorcinol / sulfur topical Breastfeeding Warnings

The manufacturer makes no recommendation regarding use during lactation.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

Comments:
-The effects in the nursing infant are unknown.
-LactMed: Sulfur 5% to 10% in a petrolatum base is considered safe for topical use in children (including infants younger than 2 months).

See references

Does Resorcinol/sulfur topical interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

See also

References for pregnancy information

  1. (2004) "Product Information. Bensulfoid (resorcinol-sulfur topical)." ECR Pharmaceuticals

References for breastfeeding information

  1. (2004) "Product Information. Bensulfoid (resorcinol-sulfur topical)." ECR Pharmaceuticals
  2. United States National Library of Medicine (2013) Toxnet. Toxicology Data Network. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer